Reuters logo
BRIEF-Thermo Fisher Scientific signs development agreement with Agios Pharmaceuticals
May 18, 2017 / 12:13 PM / 6 months ago

BRIEF-Thermo Fisher Scientific signs development agreement with Agios Pharmaceuticals

May 18 (Reuters) - Thermo Fisher Scientific Inc

* Thermo Fisher Scientific signs development agreement with Agios Pharmaceuticals for next-generation sequencing oncology companion diagnostic in cholangiocarcinoma

* Thermo Fisher Scientific Co will retain rights to commercialize test globally and will lead necessary filings to seek clearance from regional regulatory agencies

* Says under terms of agreement, Thermo Fisher will retain rights to commercialize test globally

* Thermo Fisher Scientific says it will also lead all necessary filings to seek clearance from regional regulatory agencies

* Thermo Fisher Scientific - upon validation of CDX, it will submit a supplemental premarket approval application to expand clinical claims for its multi-therapy NGS test Source text for Eikon: Further company coverage:

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below